Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Cardiovascular dealmaking

2.1. Introduction
2.2. Cardiovascular partnering over the years
2.3. Cardiovascular partnering by deal type
2.4. Cardiovascular partnering by industry sector
2.5. Cardiovascular partnering by stage of development
2.6. Cardiovascular partnering by technology type
2.7. Cardiovascular partnering by therapeutic indication

Chapter 3 –Financial deal terms for Cardiovascular partnering

3.1. Introduction
3.2. Disclosed financials terms for Cardiovascular partnering
3.3. Cardiovascular partnering headline values
3.4. Cardiovascular deal upfront payments
3.5. Cardiovascular deal milestone payments
3.6. Cardiovascular royalty rates

Chapter 4 – Leading Cardiovascular deals and dealmakers

4.1. Introduction
4.2. Most active in Cardiovascular partnering
4.3. List of most active dealmakers in Cardiovascular
4.4. Top Cardiovascular deals by value

Chapter 5 – Cardiovascular contract document directory

5.1. Introduction
5.2. Cardiovascular partnering deals where contract document available

Chapter 6 – Cardiovascular dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Cardiovascular therapeutic target

Appendices

Appendix 1 – Directory of Cardiovascular deals by company A-Z 2014 to 2021
Appendix 2 – Directory of Cardiovascular deals by deal type 2014 to 2021
Appendix 3 – Directory of Cardiovascular deals by stage of development 2014 to 2021
Appendix 4 – Directory of Cardiovascular deals by technology type 2014 to 2021
Further reading on dealmaking
Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

Table of figures

Figure 1: Cardiovascular partnering since 2014
Figure 2: Cardiovascular partnering by deal type since 2014
Figure 3: Cardiovascular partnering by industry sector since 2014
Figure 4: Cardiovascular partnering by stage of development since 2014
Figure 5: Cardiovascular partnering by technology type since 2014
Figure 6: Cardiovascular partnering by indication since 2014
Figure 7: Cardiovascular deals with a headline value
Figure 8: Cardiovascular deals with upfront payment values
Figure 9: Cardiovascular deals with milestone payment
Figure 10: Cardiovascular deals with royalty rates
Figure 11: Active Cardiovascular dealmaking activity– 2014 to 2021
Figure 12: Top Cardiovascular deals by value since 2014